Skip to main content
. Author manuscript; available in PMC: 2010 Jul 11.
Published in final edited form as: J Cardiometab Syndr. 2009 Spring;4(2):113–119. doi: 10.1111/j.1559-4572.2008.00044.x

Figure 2.

Figure 2

(A) Age-adjusted prevalence of coronary heart disease (CHD) in the US population older than 50 years according the presence of the metabolic syndrome (MS) and diabetes mellitus (DM) (adapted from Alexander et al, 200312). (B) Prevalence of patients with major cardiovascular disease events in all patients in the Treating to New Targets study by MS and DM status (adapted from Deedwania et al, 200620). *Hazard ratio for patients with MS and diabetes vs patients without MS or diabetes. †Hazard ratio for patients with MS without diabetes vs patients without MS or diabetes.